These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tardive dyskinesia: prevalence and risk factors, 1959 to 1979. Kane JM, Smith JM. Arch Gen Psychiatry; 1982 Apr; 39(4):473-81. PubMed ID: 6121548 [Abstract] [Full Text] [Related]
3. Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study. Morgenstern H, Glazer WM. Arch Gen Psychiatry; 1993 Sep; 50(9):723-33. PubMed ID: 8102845 [Abstract] [Full Text] [Related]
13. Persistent tardive dyskinesia in bipolar patients. Mukherjee S, Rosen AM, Caracci G, Shukla S. Arch Gen Psychiatry; 1986 Apr; 43(4):342-6. PubMed ID: 2869742 [Abstract] [Full Text] [Related]
14. A survey of tardive dyskinesia in psychiatric inpatients in Japan. Koshino Y, Madokoro S, Ito T, Horie T, Mukai M, Isaki K. Clin Neuropharmacol; 1992 Feb; 15(1):34-43. PubMed ID: 1349507 [Abstract] [Full Text] [Related]
17. Factors in the development of severe forms of tardive dyskinesia. Yassa R, Nair NP, Iskander H, Schwartz G. Am J Psychiatry; 1990 Sep; 147(9):1156-63. PubMed ID: 1974745 [Abstract] [Full Text] [Related]
18. Tardive dyskinesia in an outpatient population: prevalence and predisposing factors. Yassa R, Ananth J, Cordozo S, Ally J. Can J Psychiatry; 1983 Aug; 28(5):391-4. PubMed ID: 6138143 [Abstract] [Full Text] [Related]
19. [Occurrence of tardive dyskinesia during neuroleptic treatment]. Fanget F, Henry E, Aimard G. Presse Med; 1986 Dec 06; 15(43):2147-50. PubMed ID: 2884657 [Abstract] [Full Text] [Related]
20. Focus on lower risk of tardive dyskinesia with atypical antipsychotics. Nasrallah HA. Ann Clin Psychiatry; 2006 Dec 06; 18(1):57-62. PubMed ID: 16517454 [Abstract] [Full Text] [Related] Page: [Next] [New Search]